Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
|2||Active, not recruiting||
Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism
Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients
Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism
Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT
† Study has passed its completion date and status has not been verified in more than two years.